Aerovate Therapeutics
AVTE
#9151
Rank
A$0.12 B
Marketcap
$4.17
Share price
1.56%
Change (1 day)
-87.77%
Change (1 year)

EPS for Aerovate Therapeutics (AVTE)

EPS in 2023 (TTM): -$3.90

According to Aerovate Therapeutics's latest financial reports the company's current EPS (TTM) is -$4.17. In 2022 the company made an earnings per share (EPS) of -$3.38 an increase over its 2021 EPS that were of -$39.33.

EPS history for Aerovate Therapeutics from 2020 to 2023

20212022-$50-$40-$30-$20-$10$100companiesmarketcap.com

Annual EPS

Year EPS Change
2023 (TTM)-$3.9015.33%
2022-$3.38-91.4%
2021-$39.33-29.07%
2020-$55.45